« Back to Record
Citation APA

Molina, L., Zhu, J., Trepo, E., Bayard, Q., Amaddeo, G., Le Bail, B., Chiche, L., Bioulac-Sage, P., Balabaud, C., Possenti, L., Decraecker, M., Paradis, V., Laurent, A., Blanc, J. F., Calderaro, J., Ma, X., Zucman-Rossi, J., & Letouzé, E. (2022). Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. Journal of hepatology. doi:10.1016/j.jhep.2022.05.018


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346854

Molina, L., Zhu, J., Trepo, E., Bayard, Q., Amaddeo, G., Le Bail, B., Chiche, L., Bioulac-Sage, P., Balabaud, C., Possenti, L., Decraecker, M., Paradis, V., Laurent, A., Blanc, J. F., Calderaro, J., Ma, X., Zucman-Rossi, J., & Letouzé, E. (2022). Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. Journal of hepatology. doi:10.1016/j.jhep.2022.05.018